Latest Schedule 13G passive stakes
NASDAQ
SCHEDULE: HeartCore Enterprises Stake Acquired
Hnatko Capital Inc. and Christopher Hnatko report beneficial ownership of 7.1% of HeartCore Enterprises, Inc. common stock.
NASDAQ
Samda Biolab Co., Ltd. has reported beneficial ownership of 3,426,548 shares, representing 5.1% of Liminatus Pharma, Inc.'s common stock.
NYSE
Pzena Investment Management LLC has reported a significant beneficial ownership stake of 7.5% in MasterBrand, Inc., holding over 15.3 million shares.
NYSE
Pzena Investment Management, LLC has disclosed a significant beneficial ownership stake of 7.5% in Masterbrand Inc., holding 15,329,483 shares.
AMEX
BURU
Nuburu, INCAvondale Capital, LLC, along with affiliated entities and John M. Fife, has reported beneficial ownership of 32,154,340 shares of Nuburu, Inc. common stock, representing 8.8% of the outstanding shares.
NASDAQ
Shikiar Asset Management Inc. has reported beneficial ownership of 151,880 Series D Cumulative Perpetual Preferred Shares in FTAI Aviation Ltd., representing 5.8% of the class.
NYSE
RP Investment Advisors LP and affiliated funds have reported beneficial ownership of over 5% of CH4 Natural Solutions Corp's Class A Ordinary Shares.
NYSE
CINT
Ci&T INCRoyce & Associates LP has filed an amended Schedule 13G, reporting beneficial ownership of 3.02% of CI&T Inc's Class A Common Stock as of June 30, 2026.
NASDAQ
TRNS
Transcat INCRoyce & Associates LP has filed an amended Schedule 13G, reporting beneficial ownership of 4.62% of Transcat, Inc. common stock as of June 30, 2026.
NYSE
JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting beneficial ownership of McDonald's Corporation common stock.
NYSE
JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting beneficial ownership of McDonald's Corporation common stock.
NASDAQ
Royce & Associates LP has disclosed a 3.39% ownership stake in OneWater Marine Inc. as of June 30, 2026.
NYSE
SCHEDULE: JPMorgan Chase Discloses Insmed Stake
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 4.7% of Insmed Incorporated's common stock as of June 30, 2026.
NASDAQ
INSM
Insmed INCSCHEDULE: JPMorgan Chase Discloses Insmed Stake
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 4.7% of Insmed Incorporated's common stock as of June 30, 2026.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 18,118,656 shares, representing 4.5% of Howmet Aerospace Inc.'s common stock.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 18,118,656 shares, representing 4.5% of Howmet Aerospace Inc.'s common stock.
NYSE
Royce & Associates LP has disclosed a beneficial ownership of 7.18% in Luxfer Holdings PLC, holding 1,939,410 shares.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 4.3% of Healthpeak Properties, Inc. common stock as of June 30, 2026.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 4.3% of Healthpeak Properties, Inc. common stock as of June 30, 2026.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 4.8% of Hayward Holdings, Inc. common stock as of June 30, 2026.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 4.8% of Hayward Holdings, Inc. common stock as of June 30, 2026.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 4.8% of CSLM Digital Asset Acquisition Corp III, Ltd.'s Class A ordinary shares.
NASDAQ
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 4.8% of CSLM Digital Asset Acquisition Corp III, Ltd.'s Class A ordinary shares.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 3.3% of Cerebras Systems Inc. Class A common stock as of June 30, 2026.
NASDAQ
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 3.3% of Cerebras Systems Inc. Class A common stock as of June 30, 2026.
NYSE
JPMorgan Chase & Co. has reported a beneficial ownership of 4.8% in Cartesian Therapeutics, Inc., holding 1,486,252 shares.
NASDAQ
JPMorgan Chase & Co. has reported a beneficial ownership of 4.8% in Cartesian Therapeutics, Inc., holding 1,486,252 shares.
NASDAQ
Royce & Associates LP has disclosed a beneficial ownership stake of 5.09% in Westport Fuel Systems Inc., holding 1,131,479 shares.
NYSE
Royce & Associates LP has filed a Schedule 13G, reporting beneficial ownership of 9.18% of TrueBlue, Inc. common stock as of June 30, 2026.
NYSE
Royce & Associates LP has disclosed a beneficial ownership of 5.46% in Ranger Energy Services, Inc.'s Class A Common Stock as of June 30, 2026.